For investors
An operating partner inside your portfolio.
Senior operators inside the companies you hold, for faster first revenue and less capital spent on market entry.
The cost
Approval is where science risk becomes commercial risk.
Three things slow first revenue after approval.
Slow market entry
The wrong first market, or the right one too late.
Hospital tenders
Pilots that stop at procurement.
Reimbursement uncertainty
Payers asking for evidence the approval did not need.
What we do for investors
Operator depth, wherever your portfolio needs it.
Six ways funds and family offices work with us. Each is scoped and priced per engagement.
Before you invest
Curated deal flow
Health companies and ventures matched to your thesis, from our network and our studio.
Before you invest
Due diligence and deep dives
The regulatory, clinical, and commercial case tested by operators before you commit.
Before you invest
Market intelligence
Markets, payers, and competitors mapped for a thesis or a portfolio company.
Inside your portfolio companies
Commercial and clinical strategy
An operator’s view of the route to revenue and the evidence it will need.
Inside your portfolio companies
Fractional leadership
Senior operators inside portfolio companies, as interim commercial or market-access leads.
Together
Partnerships and ventures
Joint ventures, co-builds, and strategic partnerships explored together.
- Scope and milestones agreed before work starts
- Paid in cash and success fees
- A Senior Partner leads every engagement
Who you work with
Operators who have run these markets.
Two of our ventures are live. See our ventures.
- 46+years combined at Roche, Novartis, and MSD, between Daren Wilson and Safia Agueni
- 35+Expert Community specialists
- ~10Network Partners
- 2ventures live: Venitara (opens in a new tab) (announced 15 September 2026) and ZINOS (opens in a new tab)
Where we work
- US into Europe Open now
- Europe into the US In preparation
- MENA Partnerships under way
Start the conversation
Where could HealthSeed create value in your portfolio?
Tell us about your fund and what you want to explore.
This page is not an offer or a solicitation to invest.
What happens next
A first conversation, then a proposal.
- You tell us about your fund
- A Senior Partner sets up a first conversation
- You receive a proposal scoped to the company